Martina Penazzato

4.9k total citations · 1 hit paper
116 papers, 2.8k citations indexed

About

Martina Penazzato is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Martina Penazzato has authored 116 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Infectious Diseases, 37 papers in Epidemiology and 33 papers in Virology. Recurrent topics in Martina Penazzato's work include HIV/AIDS Research and Interventions (89 papers), HIV/AIDS drug development and treatment (49 papers) and HIV Research and Treatment (33 papers). Martina Penazzato is often cited by papers focused on HIV/AIDS Research and Interventions (89 papers), HIV/AIDS drug development and treatment (49 papers) and HIV Research and Treatment (33 papers). Martina Penazzato collaborates with scholars based in Switzerland, United States and United Kingdom. Martina Penazzato's co-authors include Meg Doherty, Nathan Ford, Marco Vitória, Edward J. Mills, Zara Shubber, Sabin Nsanzimana, Andrew J. Prendergast, Shaffiq Essajee, Elaine J. Abrams and Rachel Vreeman and has published in prestigious journals such as Clinical Infectious Diseases, Cochrane Database of Systematic Reviews and Journal of Clinical Microbiology.

In The Last Decade

Martina Penazzato

111 papers receiving 2.8k citations

Hit Papers

Patient-Reported Barriers to Adherence to Antiretroviral ... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
    2016 353 citations Zara Shubber, Edward J. Mills et al. PLoS Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Penazzato Switzerland 31 2.2k 1.0k 909 615 411 116 2.8k
Paul J. Weidle United States 32 2.8k 1.3× 1.5k 1.5× 1.1k 1.2× 644 1.0× 483 1.2× 95 3.5k
Joep J. van Oosterhout Malawi 31 2.4k 1.1× 1.3k 1.2× 656 0.7× 951 1.5× 503 1.2× 111 3.2k
Carolyn Bolton‐Moore United States 25 1.9k 0.9× 958 0.9× 624 0.7× 720 1.2× 330 0.8× 120 2.5k
Mhairi Maskew South Africa 34 3.1k 1.4× 1.6k 1.6× 1.3k 1.5× 773 1.3× 687 1.7× 130 3.8k
Marc Lallemant France 25 2.0k 0.9× 760 0.7× 1.1k 1.3× 393 0.6× 404 1.0× 123 2.4k
Claire Thorne United Kingdom 34 2.4k 1.1× 1.6k 1.6× 645 0.7× 702 1.1× 683 1.7× 175 3.5k
Edward M. Gardner United States 29 3.5k 1.6× 2.1k 2.1× 1.5k 1.6× 730 1.2× 649 1.6× 82 4.4k
Katerina Christopoulos United States 26 2.0k 0.9× 1.5k 1.5× 563 0.6× 674 1.1× 341 0.8× 117 2.5k
Allison L. Agwu United States 25 1.7k 0.8× 972 1.0× 465 0.5× 657 1.1× 326 0.8× 115 2.3k
C. William Wester United States 27 1.5k 0.7× 892 0.9× 651 0.7× 449 0.7× 287 0.7× 84 2.1k

Countries citing papers authored by Martina Penazzato

Since Specialization
Citations

This map shows the geographic impact of Martina Penazzato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Penazzato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Penazzato more than expected).

Fields of papers citing papers by Martina Penazzato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Penazzato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Penazzato. The network helps show where Martina Penazzato may publish in the future.

Co-authorship network of co-authors of Martina Penazzato

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Penazzato. A scholar is included among the top collaborators of Martina Penazzato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Penazzato. Martina Penazzato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waalewijn, Hylke, Roeland E. Wasmann, Tim R. Cressey, et al.. (2025). Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas. The Lancet Child & Adolescent Health. 9(4). 274–282. 1 indexed citations
2.
Berkley, James A., Judd L. Walson, Glenda Gray, et al.. (2025). Strengthening the paediatric clinical trial ecosystem to better inform policy and programmes. The Lancet Global Health. 13(4). e732–e739. 3 indexed citations
3.
Penazzato, Martina, Sébastien Morin, Farihah Malik, et al.. (2025). Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network. The Lancet Child & Adolescent Health. 9(5). 337–348. 1 indexed citations
4.
Capparelli, Edmund V., Mark Mirochnick, Diana F. Clarke, et al.. (2024). Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study. Journal of Antimicrobial Chemotherapy. 79(10). 2570–2574. 1 indexed citations
5.
Mathur, Shrey, Melanie Smuk, Ceri Evans, et al.. (2024). Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study. PLoS Medicine. 21(2). e1004334–e1004334. 1 indexed citations
6.
Frigati, Lisa, Diana M. Gibb, Joseph I. Harwell, et al.. (2023). The hard part we often forget: providing care to children and adolescents with advanced HIV disease. Journal of the International AIDS Society. 26(3). e26041–e26041. 4 indexed citations
7.
Wedderburn, Catherine J., Ceri Evans, Amy L. Slogrove, et al.. (2023). Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review. Journal of the International AIDS Society. 26(6). e26079–e26079. 6 indexed citations
8.
Barbieri, Elisa, Chiara Minotti, Carlo Giaquinto, et al.. (2023). Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project. Frontiers in Pharmacology. 14. 1200848–1200848. 4 indexed citations
9.
Townsend, Claire L, Edith B. Milanzi, Intira Jeannie Collins, et al.. (2023). Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review. Journal of the International AIDS Society. 26(2). e26037–e26037. 4 indexed citations
10.
Townsend, Claire L, Edith B. Milanzi, Intira Jeannie Collins, et al.. (2022). Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review. Journal of the International AIDS Society. 25(11). e25970–e25970. 14 indexed citations
11.
Penazzato, Martina, Shahin Lockman, Angela Colbers, et al.. (2022). Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. Journal of the International AIDS Society. 25(S2). e25912–e25912. 6 indexed citations
12.
Penazzato, Martina, Clare Flanagan, Elaine J. Abrams, et al.. (2022). Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes. Journal of the International AIDS Society. 25(12). e26045–e26045. 5 indexed citations
13.
Rojo, Pablo, Deborah Carpenter, François Venter, Anna Turkova, & Martina Penazzato. (2020). The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV. Journal of the International AIDS Society. 23(S5). e25576–e25576. 6 indexed citations
14.
Inzaule, Seth, Michael R. Jordan, George Bello, et al.. (2020). High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa. AIDS. 34(10). 1567–1570. 7 indexed citations
15.
Penazzato, Martina, Sébastien Morin, Linda Lewis, et al.. (2018). Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action. The Lancet HIV. 5(5). e259–e264. 8 indexed citations
16.
Shubber, Zara, Edward J. Mills, Jean B. Nachega, et al.. (2016). Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Medicine. 13(11). e1002183–e1002183. 353 indexed citations breakdown →
17.
Bouazza, Naïm, Tim R. Cressey, Frantz Foissac, et al.. (2016). Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients. Journal of Antimicrobial Chemotherapy. 72(2). 490–495. 3 indexed citations
18.
Petrara, Maria Raffaella, Martina Penazzato, William Massavon, et al.. (2014). Epstein-Barr Virus Load in Children Infected With Human Immunodeficiency Virus Type 1 in Uganda. The Journal of Infectious Diseases. 210(3). 392–399. 16 indexed citations
19.
Penazzato, Martina, et al.. (2009). Update on antiretroviral therapy in paediatrics. Antiviral Research. 85(1). 266–275. 5 indexed citations
20.
Giaquinto, Carlo, et al.. (2007). Nucleoside and Nucleotide Reverse Transcriptase Inhibitors in Children. Clinical Drug Investigation. 27(8). 509–531. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul J. Weidle Breakdown of academic impact, for papers by Joep J. van Oosterhout Breakdown of academic impact, for papers by Carolyn Bolton‐Moore Breakdown of academic impact, for papers by Mhairi Maskew Breakdown of academic impact, for papers by Marc Lallemant Breakdown of academic impact, for papers by Claire Thorne Breakdown of academic impact, for papers by Edward M. Gardner Breakdown of academic impact, for papers by Katerina Christopoulos Breakdown of academic impact, for papers by Allison L. Agwu Breakdown of academic impact, for papers by C. William Wester
Rankless by CCL
2026